BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29338089)

  • 1. Outcomes of patients diagnosed with carcinoma metastatic to the neck from an unknown primary source and treated with intensity-modulated radiation therapy.
    Kamal M; Mohamed ASR; Fuller CD; Sturgis EM; Johnson FM; Morrison WH; Gunn GB; Hutcheson KA; Phan J; Volpe S; Ng SP; Ferrarotto R; Frank SJ; Skinner HD; Rosenthal DI; Garden AS
    Cancer; 2018 Apr; 124(7):1415-1427. PubMed ID: 29338089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure.
    Frank SJ; Rosenthal DI; Petsuksiri J; Ang KK; Morrison WH; Weber RS; Glisson BS; Chao KS; Schwartz DL; Chronowski GM; El-Naggar AK; Garden AS
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1005-10. PubMed ID: 20207504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unknown primary head and neck cancer treated with intensity-modulated radiation therapy: to what extent the volume should be irradiated.
    Lu H; Yao M; Tan H
    Oral Oncol; 2009 Jun; 45(6):474-9. PubMed ID: 18804408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
    Villeneuve H; Després P; Fortin B; Filion E; Donath D; Soulières D; Guertin L; Ayad T; Christopoulos A; Nguyen-Tan PF
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1866-71. PubMed ID: 21497452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio?
    Chen AM; Farwell DG; Lau DH; Li BQ; Luu Q; Donald PJ
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):346-52. PubMed ID: 20933340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial experience with oropharynx-targeted radiation therapy for metastatic squamous cell carcinoma of unknown primary of the head and neck.
    Mourad WF; Hu KS; Shasha D; Concert C; Ishihara D; Lin W; Shourbaji RA; Ryniak M; Gamez ME; Lukens JN; Li Z; Culliney BE; Khorsandi AS; Tran T; Jacobson A; Manolidis S; Schantz S; Urken M; Persky MS; Harrison LB
    Anticancer Res; 2014 Jan; 34(1):243-8. PubMed ID: 24403470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unknown primary head and neck squamous cell carcinoma in the era of fluorodeoxyglucose-positron emission tomography/CT and intensity-modulated radiotherapy.
    de Ridder M; Klop M; Hamming-Vrieze O; de Boer J; Jasperse B; Smit L; Vogel W; van den Brekel M; Al-Mamgani A
    Head Neck; 2017 Jul; 39(7):1382-1391. PubMed ID: 28370570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
    Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary.
    Ligey A; Gentil J; Créhange G; Montbarbon X; Pommier P; Peignaux K; Truc G; Maingon P
    Radiother Oncol; 2009 Dec; 93(3):483-7. PubMed ID: 19892420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy.
    Yao M; Lu M; Savvides PS; Rezaee R; Zender CA; Lavertu P; Buatti JM; Machtay M
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):684-9. PubMed ID: 22169673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of patients with head-and-neck cancer of unknown primary origin treated with intensity-modulated radiotherapy.
    Shoushtari A; Saylor D; Kerr KL; Sheng K; Thomas C; Jameson M; Reibel J; Shonka D; Levine P; Read P
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e83-91. PubMed ID: 21377283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment for retropharyngeal metastatic undifferentiated squamous cell carcinoma from an unknown primary site: results of a prospective study with irradiation to nasopharyngeal mucosa plus bilateral neck.
    Du C; Ying H; Zhang Y; Huang Y; Zhai R; Hu C
    Oncotarget; 2017 Jun; 8(26):42372-42381. PubMed ID: 28418897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neck lymph node metastases from an unknown primary tumor retrospective study and review of literature.
    Christiansen H; Hermann RM; Martin A; Nitsche M; Schmidberger H; Pradier O
    Strahlenther Onkol; 2005 Jun; 181(6):355-62. PubMed ID: 15925977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved dosimetric and clinical outcomes with intensity-modulated radiotherapy for head-and-neck cancer of unknown primary origin.
    Chen AM; Li BQ; Farwell DG; Marsano J; Vijayakumar S; Purdy JA
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):756-62. PubMed ID: 20421143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of care analysis for head & neck cancer of unknown primary site: a survey inside the German society of radiation oncology (DEGRO).
    Müller von der Grün J; Bon D; Rödel C; Balermpas P
    Strahlenther Onkol; 2018 Aug; 194(8):750-758. PubMed ID: 29761228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and toxicity of chemoradiotherapy using intensity-modulated radiotherapy for unknown primary of head and neck.
    Sher DJ; Balboni TA; Haddad RI; Norris CM; Posner MR; Wirth LJ; Goguen LA; Annino D; Tishler RB
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1405-11. PubMed ID: 21177045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy Characteristics and Outcomes for Head and Neck Carcinoma of Unknown Primary vs T1 Base-of-Tongue Carcinoma.
    Hosni A; Dixon PR; Rishi A; Au M; Xu W; Song Y; Chepeha DB; Goldstein DP; Huang SH; Kim J; O'Sullivan B; Waldron J; Bratman SV; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1208-1215. PubMed ID: 27812692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses.
    Takiar V; Garden AS; Ma D; Morrison WH; Edson M; Zafereo ME; Gunn GB; Fuller CD; Beadle B; Frank SJ; William WN; Kies M; El-Naggar AK; Weber R; Rosenthal DI; Phan J
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1117-31. PubMed ID: 27354127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and management of squamous cell carcinoma of the head and neck region with unknown primary. A survey of 167 patients].
    Issing WJ; Taleban B; Tauber S
    Laryngorhinootologie; 2003 Sep; 82(9):659-65. PubMed ID: 14517763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.